Yuhan Corporation
000100
Rankning i aktier
#3833
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in... Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
Aktiekurs
$63.22
Marknadsvärde
$4.27B
Förändring (1 dag)
-3.12%
Förändring (1 år)
-23.57%
Land
KR
Handel Yuhan Corporation (000100)
Kategori
Healthcare
Antal utestående aktier för Yuhan Corporation (000100)
Antal utestående aktier per June 2026: 85.45M
Enligt de senaste finansiella rapporterna och aktiekursen för Yuhan Corporation är det aktuella antalet utestående aktier 85.45M. I slutet av December 2024 hade företaget 74.96M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Yuhan Corporation (000100) från 2007 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2026 (TTM) | 85.45M | 5.29% |
| 2025 | 81.15M | 8.26% |
| 2024 | 74.96M | -0.05% |
| 2023 | 75.00M | -0.25% |
| 2022 | 75.19M | -0.54% |
| 2021 | 75.59M | -0.19% |
| 2020 | 75.74M | 4.86% |
| 2019 | 72.23M | 4.54% |
| 2018 | 69.09M | 1.05% |
| 2017 | 68.38M | -0.62% |
| 2016 | 68.80M | -4.83% |
| 2015 | 72.29M | -0.71% |
| 2014 | 72.81M | -1.12% |
| 2013 | 73.63M | -0.02% |
| 2012 | 73.65M | -1.42% |
| 2011 | 74.71M | -4.01% |
| 2010 | 77.83M | -1.28% |
| 2009 | 78.84M | 2.50% |
| 2008 | 76.91M | -2.25% |
| 2007 | 78.68M | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| 434.78M | 408.84% |
DE
|
|
| 434.78M | 408.84% |
DE
|
|
| 1.56B | 1,728.75% |
JP
|
|
| 233.66M | 173.46% |
CH
|
|
| 2.40B | 2,708.05% |
IN
|
